PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Crunching numbers to combat cancer

UCSF receives $5 million to integrate data from cancer research models

2015-09-15
(Press-News.org) UC San Francisco has received a National Cancer Institute grant of $5 million over the next five years to lead a massive effort to integrate the data from all experimental models across all types of cancer. The web-based repository is an important step in moving the fight against cancer toward precision medicine.

The goal is to accelerate cancer research to improve the way we diagnose, treat and conduct further research on the disease. The resulting database, called the Oncology Models Forum (OMF), will be accessible to researchers through the National Institutes of Health, to encourage scientists to use existing validated cancer models, rather than creating new ones.

"There are incredible new discoveries happening in cancer research today, such as detecting cancer cells and DNA in the blood stream, and even harnessing the immune system to fight cancers," said Atul Butte, MD, PhD, director of the Institute for Computational Health Sciences at UCSF and principal investigator for the grant. "These research methodologies generate enormous amounts of data that can and should be harnessed by researchers and engineers to yield new drugs and diagnostics."

Cell lines and mice have been placeholders for studying human cancer for decades, resulting in thousands of mouse models for all cancer types. While results from those studies are chronicled in scientific papers and journals, it is difficult to know how relevant the data from these experimental systems are to the actual research and development of drugs and diagnostics in actual human cancers.

This is particularly important, Butte said, because there can be a gap of up to 10 years between the early basic science discoveries from experimental systems and the actual clinical trial of the drug candidates that are developed from that science, with many drug candidates failing in those clinical trials. As a result, it is critically important to ensure that early scientific discoveries are in fact relevant to human cancers, to provide every possible hope that the eventual drugs developed from those discoveries will work in clinical trials and be available to cancer patients.

The project aims to create an online cache of molecular data that oncologists and cancer researchers could use to validate the current models that best translate to humans, make predictions about the disease and move toward a collaborative, precision medicine approach to cancer. Ultimately, Butte said, the effort also has the potential to create computer-based cancer models that greatly reduce the need for using animals in research.

The project, led by the UCSF Institute for Computational Health Sciences, will collaborate with Alejandro Sweet-Cordero, MD, Julien Sage, PhD, and Nigam Shah, PhD, at Stanford University, who will provide support with the latest genetically-engineered cancer models, as well as standardized nomenclatures. It also will include bioinformatics specialists from the Northrop Grumman Corp., who will help build and maintain the online database.

INFORMATION:

UC San Francisco (UCSF) is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. It includes top-ranked graduate schools of dentistry, medicine, nursing and pharmacy, a graduate division with nationally renowned programs in basic, biomedical, translational and population sciences, as well as a preeminent biomedical research enterprise and two top-ranked hospitals, UCSF Medical Center and UCSF Benioff Children's Hospital San Francisco.



ELSE PRESS RELEASES FROM THIS DATE:

New drugs could stop the growth of drug-resistant childhood tumors

2015-09-15
Current drugs may stop working against the most common type of brain tumor in children, medulloblastoma, but the tumor could be targeted in a new way, according to Stanford University scientists. In research to be published in the journal eLife, a team led by Prof. Matthew P. Scott at the University's School of Medicine tested a drug called Roflumilast in mice with a brain tumor that is resistant to Vismodegib, the drug in current use. Roflumilast is normally used to treat inflammatory lung diseases. It dramatically inhibited tumor growth from the first day of treatment. ...

Research breakthrough in fight against muscle wasting diseases

Research breakthrough in fight against muscle wasting diseases
2015-09-15
This news release is available in French. Montreal, September 15th 2015 - It is estimated that half of all cancer patients suffer from a muscle wasting syndrome called cachexia. Cancer cachexia impairs quality of life and response to therapy, which increases morbidity and mortality of cancer patients. Currently, there is no approved treatment for muscle wasting but a new study from the Research Institute of the McGill University Health Centre (RI-MUHC) and University of Alberta could be a game changer for patients, improving both quality of life and longevity. The ...

World loses trillions of dollars worth of nature's benefits each year due to land degradation

World loses trillions of dollars worth of natures benefits each year due to land degradation
2015-09-15
To better inform the tradeoffs involved in land use choices around the world, experts have assessed the value of ecosystem services provided by land resources such as food, poverty reduction, clean water, climate and disease regulation and nutrients cycling. Their report today estimates the value of ecosystem services worldwide forfeited due to land degradation at a staggering US $6.3 trillion to $10.6 trillion annually, or the equivalent of 10-17% of global GDP. Furthermore, the problem threatens to force the migration of millions of people from affected areas. ...

New efficiency record for solar hydrogen production is 14 percent

New efficiency record for solar hydrogen production is 14 percent
2015-09-15
Solar energy is abundantly available globally, but unfortunately not constantly and not everywhere. One especially interesting solution for storing this energy is artificial photosynthesis. This is what every leaf can do, namely converting sunlight to chemical energy. That can take place with artificial systems based on semiconductors as well. These use the electrical power that sunlight creates in individual semiconductor components to split water into oxygen and hydrogen. Hydrogen possesses very high energy density, can be employed in many ways and could replace fossil ...

Researchers explore cocoa as novel dietary source for prevention of cognitive deterioration in AD

2015-09-15
Amsterdam, NL, September 9, 2015 - The potential benefits of dietary cocoa extract and/or its final product in the form of chocolate have been extensively investigated in regard to several aspects of human health. Cocoa extracts contain polyphenols, which are micronutrients that have many health benefits, including reducing age-related cognitive dysfunction and promoting healthy brain aging, among others. Dr. Giulio Maria Pasinetti, MD, PhD, Saunders Family Chair and Professor of Neurology at the Icahn School of Medicine at Mount Sinai, Director of Biomedical Training ...

MRI improves diagnosis of microbleeding after brain injury in military personnel

MRI improves diagnosis of microbleeding after brain injury in military personnel
2015-09-15
OAK BROOK, Ill. - Imaging patients soon after traumatic brain injury (TBI) occurs can lead to better (more accurate) detection of cerebral microhemorrhages, or microbleeding on the brain, according to a study of military service members, published online in the journal Radiology. Cerebral microhemorrhages occur as a direct result of TBI and can lead to severe secondary injuries such as brain swelling or stroke. The ability to monitor the evolution of microhemorrhages could provide important information regarding disease progression or recovery. According to the Centers ...

Effects of prenatal myelomeningocele closure on the need for a CSF shunt

2015-09-15
CHARLOTTESVILLE, VA (SEPTEMBER 15, 2015). Management of Myelomeningocele Study (MOMS) investigators analyzed updated data on the effects of prenatal myelomeningocele closure on the need for placement of a cerebrospinal fluid (CSF) shunt within the first 12 months of life. These researchers reaffirm the initial MOMS finding that prenatal repair of a myelomeningocele results in less need for a shunt at 12 months and introduce the new finding that prenatal repair reduces the need for shunt revision in those infants who do require shunt placement. The researchers also found ...

Link between air pollution, increased deaths and increased deaths from heart disease affirmed

2015-09-15
In what is believed to be the largest, most detailed study of its kind in the United States, scientists at NYU Langone Medical Center and elsewhere have confirmed that tiny chemical particles in the air we breathe are linked to an overall increase in risk of death. The researchers say this kind of air pollution involves particles so small they are invisible to the human eye (at less than one ten-thousandth of an inch in diameter, or no more than 2.5 micrometers across). In a report on the findings, published in the journal Environmental Health Perspectives online Sept. ...

'Our chairs are killing us,' say researchers

2015-09-15
Amsterdam, The Netherlands, September 15, 2015 -- Prolonged sitting time as well as reduced physical activity contribute to the prevalence of non-alcoholic fatty liver disease (NAFLD) in a study of middle-aged Koreans. These findings support the importance of both reducing time spent sitting and increasing physical activity, say researchers. Their results are published in the Journal of Hepatology. Physical activity is known to reduce the incidence and mortality of various chronic diseases. However, more than one half of the average person's waking day involves sedentary ...

Combining epigenetic therapies with immunotherapies likely to improve cancer patient outcomes

2015-09-15
PHILADELPHIA -- Recent data suggest that epigenetic therapies are likely to provide additional clinical benefit to cancer patients when rationally combined with immunotherapeutic drugs, according to a review published in Clinical Cancer Research, a journal of the American Association for Cancer Research. "The term epigenetics refers to the study of cellular changes in gene expression that are heritably transmitted during cell replication," said Michele Maio, MD, PhD, chair of medical oncology and immunotherapy, Ospedale Santa Maria alle Scotte, Istituto Toscano Tumori, ...

LAST 30 PRESS RELEASES:

‘Molecular shield’ placed in the nose may soon treat common hay fever trigger

Beetles under climate stress lay larger male eggs: Wolbachia infection drives adaptive reproduction strategy in response to rising temperature and CO₂

Groundbreaking quantum study puts wave-particle duality to work

Weekly injection could be life changing for Parkinson’s patients

Toxic metals linked to impaired growth in infants in Guatemala

Being consistently physically active in adulthood linked to 30–40% lower risk of death

Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks

Children’s social care involvement common to nearly third of UK mums who died during perinatal period

‘Support, not judgement’: Study explores links between children’s social care involvement and maternal deaths

Ethnic minority and poorer children more likely to die in intensive care

Major progress in fertility preservation after treatment for cancer of the lymphatic system

Fewer complications after additional ultrasound in pregnant women who feel less fetal movement

Environmental impact of common pesticides seriously underestimated

The Milky Way could be teeming with more satellite galaxies than previously thought

New study reveals surprising reproductive secrets of a cricket-hunting parasitoid fly

Media Tip Sheet: Symposia at ESA2025

NSF CAREER Award will power UVA engineer’s research to improve drug purification

Tiny parasitoid flies show how early-life competition shapes adult success

New coating for glass promises energy-saving windows

Green spaces boost children’s cognitive skills and strengthen family well-being

Ancient trees dying faster than expected in Eastern Oregon

Study findings help hone precision of proven CVD risk tool

Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later

Introducing BioEmu: A generative AI Model that enables high-speed and accurate prediction of protein structural ensembles

Replacing mutated microglia with healthy microglia halts progression of genetic neurological disease in mice and humans

New research shows how tropical plants manage rival insect tenants by giving them separate ‘flats’

Condo-style living helps keep the peace inside these ant plants

Climate change action could dramatically limit rising UK heatwave deaths

Annual heat-related deaths projected to increase significantly due to climate and population change

Researchers discover new way cells protect themselves from damage

[Press-News.org] Crunching numbers to combat cancer
UCSF receives $5 million to integrate data from cancer research models